All Stories

  1. Big data scalability based on Spark Machine Learning Libraries
  2. Biotherapies-induced neutropenia in autoimmune and auto-inflammatory disorders and other orphan diseases
  3. Big data execution time based on Spark Machine Learning Libraries
  4. Telemedicine and Cardiology in the Elderly in France: Inventory of Experiments
  5. Telemedicine and Geriatrics in France: Inventory of Experiments
  6. Signal Processing Tools for Heart Sounds Analysis Based on Time-Frequency Domain
  7. Oral cobalamin (vitamin B12) therapy in pernicious anemia
  8. Antithyroid drug-induced agranulocytosis: experience of the French centers of Pharmacovigilance with a retrospective study of more than 200 cases
  9. Analyse de la validité de contenu et de la qualité formelle des épreuves classantes nationales administrées en France de 2004 à 2011
  10. Potential clinical impact of medication discrepancies at hospital admission
  11. E-Care telemonitoring system: Extend the platform
  12. Medication Reconciliation Practices and Potential Clinical Impact of Unintentional Discrepancies
  13. Réponse de l’auteur à la correspondance à propos de l’article : « Oral cobalamin therapy: It may be perhaps time to propose international recommendations ? »
  14. Hypochromia, microcytosis and iron deficiency
  15. Bed bugs reproductive life cycle in the clothes of a patient suffering from Alzheimer’s disease results in iron deficiency anemia
  16. Anemia in elderly patients: New insight into an old disorder
  17. Oral cobalamin therapy: It may be perhaps time to propose international recommendations?
  18. Optimal management of pernicious anemia
  19. Anaemia in the elderly: An aetiologic profile of a prospective cohort of 95 hospitalised patients
  20. Gender-related analysis of the clinical presentation, treatment response and outcome in patients with immune thrombocytopenia
  21. Metabolic inflammation: Connecting obesity and insulin resistance
  22. Comment on: Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double-blind placebo-controlled crossover 4g study and an open-label 8g extension study
  23. Épreuves classantes nationales (ECN) : qu’est-ce qu’elles évaluent ?
  24. Comments on Type I bare lymphocyte syndrome
  25. Advances and innovations in the field of auscultation, with a special focus on the development of new intelligent communicating stethoscope systems
  26. Intérêt d’une démarche pédagogique structurée associée à l’utilisation de nouveaux outils de visualisation des signaux auscultatoires dans le cadre de l’apprentissage de la sémiologie auscultatoire : étude prospective auprès de 30 étudiants du deuxième...
  27. Anémie ferriprive : Etiologie et prise en charge, quoi de neuf en 2012 ?
  28. Oral Cobalamin (Vitamin B12) Therapy: From Empiricism and Personal Experience to Evidence Based Medicine and Perspective of Recommendations and Guideline
  29. IgG4-Related Systemic Disease
  30. Hypervitaminémie B12 : physiopathologie et intérêt en pratique clinique
  31. Oral Vitamin B12 Therapy
  32. Clinical presentation and management of drug-induced agranulocytosis
  33. Correspondance à propos de l’article : « Exploration d’une anémie ferriprive »
  34. Life-Threatening Autoimmune Hematological Disorders
  35. Liste des collaborateurs
  36. Carences vitaminiques
  37. Efficacité et tolérance de la vitamine B12 par voie orale chez 31 patients avec une maladie de Biermer ou une maldigestion des cobalamines alimentaires
  38. Value of 18 FDG-PET/CT in clinical practice in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome
  39. The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis
  40. F-18 FDG PET/CT as a Valuable Imaging Tool for Assessing Treatment Efficacy in Inflammatory and Infectious Diseases
  41. Efficacy of oral cobalamin (vitamin B12) therapy
  42. Natural killer cells in atopic and autoimmune diseases of the skin
  43. NK Cell Education and CIS Interaction Between Inhibitory NK Cell Receptors and Their Ligands
  44. NK Cells in Autoimmune and Inflammatory Diseases
  45. Acquire, analyze and share auscultation sounds: The ASAP project
  46. « Altération de l’état général » : une terminologie non médicale, mais utile pour le grand public
  47. A French national research project to the creation of an auscultation's school: The ASAP project
  48. Pubalgie chez un sportif traité par atorvastatine
  49. CD56 bright natural killer (NK) cells: an important NK cell subset
  50. Update of Food-Cobalamin Malabsorption and Oral Cobalamin Therapy
  51. Recognition and management of drug-induced cytopenias: the example of idiosyncratic drug-induced thrombocytopenia
  52. An Optimized Communication for Emergency Health Situations
  53. The ASAP project: A first step to an auscultation's school creation
  54. Syndrome de non-dissociation de la vitamine B12 de ses proteines porteuses ou de maldigestion des cobalamines alimentaires
  55. Cover Picture: Eur. J. Immunol. 11/08
  56. Update of nutrient-deficiency anemia in elderly patients
  57. NK cells and Treg cells: A fascinating dance cheek to cheek
  58. Idiopathic thrombocytopenic purpura in elderly patients: A study of 47 cases from a single reference center
  59. Anémies carentielles du sujet âgé
  60. Cytopénies : plaidoyer pour une recherche clinique de qualité
  61. Thrombopénie et grossesse : du diagnostic étiologique à la prise en charge thérapeutique
  62. Agranulocytoses médicamenteuses idiosyncrasiques
  63. Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis
  64. De l’intérêt de caractériser les sons de l’auscultation pulmonaire à la création d’une école de l’auscultation
  65. Place de la TEP-FDG dans l’exploration des fièvres et syndromes inflammatoires prolongés
  66. Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: The tumour might strike back
  67. Hematological manifestations related to cobalamin deficiency in elderly patients
  68. Idiosyncratic drug-induced agranulocytosis or acute neutropenia
  69. Update on Oral Cyanocobalamin (Vitamin B12) Treatment in Elderly Patients
  70. Cobalamin Deficiency in Elderly Patients: A Personal View
  71. Proliférations cellulaires “atypiques” ou “orphelines”: actualités et perspectives
  72. Phenotypic Studies of Natural Killer Cell Subsets in Human Transporter Associated with Antigen Processing Deficiency
  73. Clinical aspects of cobalamin deficiency in elderly patients. Epidemiology, causes, clinical manifestations, and treatment with special focus on oral cobalamin therapy
  74. Parvovirus B19 infection as a cause of cytopenia with a lupus-like presentation in the elderly: A case report
  75. Aggressive form of multiple myeloma presenting with specific pleural effusion, neutrophilia, and eosinophilia
  76. Idiosyncratic drug-induced agranulocytosis: Update of an old disorder
  77. Pseudo-thrombotic Microangiopathy Related to Cobalamin Deficiency
  78. Management of idiopathic thrombocytopenic purpura in elderly patients
  79. Reduced cytokine-mediated up-regulation of HLA-DR in TAP-deficient fibroblasts
  80. Borderline Thrombocytopenia or Mild Idiopathic Thrombocytopenic Purpura?
  81. Maladie de Fabry en 2006 : une évaluation thérapeutique très limitée
  82. Primary Sjögren’s Syndrome and Vitamin B12 Deficiency: Preliminary Results in 80 Patients
  83. Natural killer cell deficiencies and severe varicella infection
  84. Les chutes : un enjeu pour la société, un enjeu pour l’individu, un enjeu pour le médecin
  85. Anorexie mentale : plaidoyer pour une recherche clinique
  86. Food-cobalamin malabsorption in elderly patients: Clinical manifestations and treatment
  87. Isolated lytic bone lesion as extramedullary disease in chronic myelogenous leukemia: A report of three new cases
  88. Usefulness of oral vitamin B12 therapy in vitamin B12 deficiency related to food-cobalamin malabsorption: Short and long-term outcome
  89. Clinical development of antimicrobial peptides
  90. Paralysie faciale récidivante, syndrome de Gougerot-Sjögren primitif et carence en vitamine B12
  91. Granulocyte-Colony Stimulating Factor (G-CSF) Therapy in Antithyroid Drug-induced Agranulocytosis
  92. Prevalence of vitamin B12 deficiency in patients with plasma cell dyscrasias
  93. Effects of oral crystalline cyanocobalamin 1000 μg/d in the treatment of pernicious anemia: An open-label, prospective study in Ten Patients
  94. The reply
  95. Artérite pulmonaire à cellules géantes révélée par une embolie pulmonaire aiguë
  96. Life-threatening pancytopenia associated with diazoxide
  97. Prognostic factors of hematological recovery in life-threatening nonchemotherapy drug-induced agranulocytosis
  98. Life-threatening anemia related to pernicious anemia cured with oral cyanocobalamin therapy
  99. Interferon-alpha therapy and autoimmune manifestations
  100. Letter to the editor
  101. Glibenclamide-induced acute haemolytic anaemia revealing a G6PD-deficiency
  102. Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results
  103. Long-term outcome of patients treated with heḿatopoietic growth factors for idiosyncratic drug-induced agranulocytosis
  104. Vitamin B12 Deficiency Associated with Chronic Acid Suppression Therapy
  105. Hematological findings in patients with Food-Cobalamin malabsorption
  106. The value of the Von Reyn and the Duke diagnostic criteria for infective endocarditis in internal medicine practice. A study of 38 cases
  107. Trimethoprim-Sulfamethoxazole–Induced Life-Threatening Agranulocytosis
  108. Treatment of hepatic relapse of multicentric Castleman’s disease with transplantation
  109. The syndrome of food-cobalamin malabsorption revisited in a department of internal medicine. A monocentric cohort study of 80 patients
  110. Does Metformin Interfere With Thiamine?—Reply
  111. Does Metformin Interfere With Thiamine?—Reply
  112. Oral chemotherapy in colorectal cancer treatment: review of the literature
  113. Short-term oral cobalamin therapy for food-related cobalamin malabsorption
  114. Short-term oral cobalamin therapy for food-related cobalamin malabsorption
  115. A patient with adult Still’s disease and high Chlamydia trachomatis titers
  116. Comment: Treatment of Vitamin B12 Deficiency Anemia: Oral versus Parenteral Therapy
  117. Comment: treatment of vitamin B12 deficiency anemia: oral versus parenteral therapy
  118. Early Normalization of Low Vitamin B12 Levels by Oral Cobalamin Therapy in Three Older Patients With Pernicious Anemia
  119. Food-cobalamin malabsorption in the elderly
  120. Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature
  121. Nonchemotherapy drug-induced agranulocytosis in elderly patients: the effects of granulocyte colony-stimulating factor
  122. Sensitivity of the criteria used to diagnose adult still’s disease in internal medicine practice. a study of 17 cases
  123. Contributors
  124. Primary humoral immunodeficiency (late-onset common variable immunodeficiency) with antinuclear antibodies and selective immunoglobulin deficiency
  125. Oral cobalamin therapy for the treatment of patients with food-cobalamin malabsorption
  126. Systemic vasculitis with necrotic purpura and acute renal failure induced by azithromycin: a case report
  127. Iliac bone defects revealing systemic sarcoidosis
  128. Lacunes osseuses iliaques révélatrices d’une sarcoïdose systémique
  129. Hearing loss due to acute leukemia
  130. High levels of coagulation factor XI as a risk factor for venous thrombosis
  131. Use of Colony-Stimulating Factors for the Treatment of Antithyroid Drug-Induced Agranulocytosis: A Retrospective Study in Twelve Patients
  132. Étude comparative entre l'enoxaparine et le placebo pour la prévention de la maladie thromboembolique veineuse en milieu médical